Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Cancer Therapeutics
  • View item
  • Home
  • ICR Divisions
  • Cancer Therapeutics
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma.

Thumbnail
View/Open
Accepted version (8.634Mb)
Date
2019-02
ICR Author
Chesler, Louis
Author
Fultang, L
Gamble, LD
Gneo, L
Berry, AM
Egan, SA
De Bie, F
Yogev, O
Eden, GL
Booth, S
Brownhill, S
Vardon, A
McConville, CM
Cheng, PN
Norris, MD
Etchevers, HC
Murray, J
Ziegler, DS
Chesler, L
Schmidt, R
Burchill, SA
Haber, M
De Santo, C
Mussai, F
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
Neuroblastoma is the most common childhood solid tumor, yet the prognosis for high-risk disease remains poor. We demonstrate here that arginase 2 (ARG2) drives neuroblastoma cell proliferation via regulation of arginine metabolism. Targeting arginine metabolism, either by blocking cationic amino acid transporter 1 (CAT-1)-dependent arginine uptake in vitro or therapeutic depletion of arginine by pegylated recombinant arginase BCT-100, significantly delayed tumor development and prolonged murine survival. Tumor cells polarized infiltrating monocytes to an M1-macrophage phenotype, which released IL1β and TNFα in a RAC-alpha serine/threonine-protein kinase (AKT)-dependent manner. IL1β and TNFα established a feedback loop to upregulate ARG2 expression via p38 and extracellular regulated kinases 1/2 (ERK1/2) signaling in neuroblastoma and neural crest-derived cells. Proteomic analysis revealed that enrichment of IL1β and TNFα in stage IV human tumor microenvironments was associated with a worse prognosis. These data thus describe an immune-metabolic regulatory loop between tumor cells and infiltrating myeloid cells regulating ARG2, which can be clinically exploited. SIGNIFICANCE: These findings illustrate that cross-talk between myeloid cells and tumor cells creates a metabolic regulatory loop that promotes neuroblastoma progression.
URI
https://repository.icr.ac.uk/handle/internal/3178
DOI
https://doi.org/10.1158/0008-5472.can-18-2139
Collections
  • Cancer Therapeutics
  • Clinical Studies
  • Molecular Pathology
Subject
Cell Line, Tumor
Macrophages
Myeloid Cells
Animals
Mice, Transgenic
Humans
Mice
Neuroblastoma
Arginase
Arginine
Tumor Necrosis Factor-alpha
MAP Kinase Signaling System
Interleukin-1beta
Tumor Microenvironment
Sarcoma, Ewing
Research team
Paediatric Solid Tumour Biology and Therapeutics
Language
eng
Date accepted
2018-12-05
License start date
2019-02
Citation
Cancer research, 2019, 79 (3), pp. 611 - 624

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.